CABHI’s Mentorship, Capital, and Continuation (MC2) Program, in partnership with National Bank, offers MC2 Capital, a first-of-its-kind investment program dedicated to supporting early-stage Canadian* healthtech and fintech companies.
Receive an investment of up to $300,000 CAD from CABHI to grow and scale your healthtech or fintech solution.
Eligible companies can access additional investment of up to $300,000 CAD from the Ontario Brain Institute, up to $150,000 CAD from Innovacorp, and business financing from Clearco.
* Due to funder requirements, the company must be located in Ontario or Nova Scotia, or, if in another part of Canada, it must have headquarters and/or traction in Ontario. See full eligibility requirements here.
As a hands-on investor, we provide you with access to acceleration services to further grow and scale your company:
Meet our 100+ subject matter experts in healthcare, industry, venture capital, and more.
Receive financing, legal, and regulatory benefits and discounts through our corporate partners.
Customer Discovery
Unlock end-user testing and customer discovery to increase sales.
Student Placements
Benefit from 100% subsidized internships and co-op placements.
Why CABHI
Since its inception, CABHI has helped companies acquire customers, grow revenues, expand sales pipelines, incorporate in new jurisdictions, and obtain carry-on investments (including seed, series A, and debentures).
To date, CABHI innovators and companies have secured more than $400M CAD in carry-on investments and more than 50% of CABHI companies have received follow-on funding.
CABHI alumni include:
- Digital physical therapy provider Sword Health, which recently attained unicorn status (valued at $2B)
- Virtual care platform Akira Health, acquired by TELUS Health
- Neurohealth technology company BrainFx, acquired by Highmark Innovations, Inc
Let us help you #getmarketready
Who You Are
Your early-stage company:
- Seeks investment capital to grow and scale
- Has a healthtech or fintech solution to improve the lives of aging adults
- Is based in Ontario or Nova Scotia, and/or has traction or headquarters in Ontario
- Meets one or more of CABHI’s five Innovation Themes
Access Your Capital
Canadian healthtech and fintech companies face an early-stage funding gap. CABHI helps close this gap by enabling access to buyers, subject matter experts, and international markets,
such as those in the US, Japan, or UK.
Each participating company will receive an investment of up to $300,000 CAD and access to CABHI’s Acceleration Services to help grow and scale their solution.
Plus, eligible companies can access additional investment up to $300,000 from the Ontario Brain Institute, up to $150,000 from Innovacorp, and business financing from Clearco.
Companies can also access additional investment opportunities through CABHI’s investor community.
What Our Companies Say about CABHI
ELIZABETH AUDETTE-BOURDEAU
CEO & Co-Founder, Welbi
“CABHI and the MC2 Capital program have opened important doors for Welbi. Their large network in the senior living industry has allowed us to accelerate our growth. The CABHI team is always there for us, ready to help, and we are grateful to be part of their portfolio.”
DEREK SHAM
Founder & CEO, Cosm Medical
“CABHI’s MC2 Capital program has been great. We worked together with CABHI on projects including value framework, health economics, and non-dilutive grant funding. I would recommend CABHI to any healthtech startup looking for a value-added investor!”
TAHIR JANMOHAMED
Founder & CEO, ManagingLife
“The MC2 Capital program came at a critical time for ManagingLife, allowing us to maintain momentum in our US commercialization and product development roadmaps. The program team and the advisor network were invaluable in terms of the guidance provided and the connections made.”
2022 Key Program Dates
Program applications open
February 1, 2022
Deadline for applications
March 1, 2022
Shortlisted applicants notified
March 10, 2022
Shortlisted applicants’ pitch day
March 16–18, 2022
CABHI Summit 2022 Pitch Competition
March 24, 2022
Due diligence process
-Data room review
-Due diligence sessions
space
April 5–22, 2022
April 25–29, 2022
Due diligence process
Data room review
April 5–23, 2021
Due diligence sessions
April 26–30, 2021
Selected applicants notified
May 17, 2022
Final date for contracts to be signed
May 31, 2022
Program start date
June 1, 2022
Get Started
Please note that applications closed on March 1, 2022.
Subscribe to our newsletter to stay up-to-date on future CABHI program offerings.
Questions about the program? Contact Jesse Mastrangelo at jmastrangelo@cabhi.com.
*Please note that companies cannot be awarded under both CABHI’s MC2 Capital Program and the Ontario Brain Institute’s NERVE Program at the same time.
Are you an investor? If you’re interested in learning more about investment opportunities with CABHI companies (or those under due diligence), you can request to join CABHI’s investor network here.
Select Partners
